- Benito-Bueno, Ángela de
- Socuéllamos, Paula G.
- Merinero, Yaiza G.
- Cercós, Pilar
- Izquierdo García, Carolina
- Daniel-Mozo, Miguel
- Marín-Olivero, Irene
- Pérez-Lara, Ángel
- González-Vera, Juan A.
- Orte, Angel
- Albert, Armando
- Martín-Martínez, Mercedes
- Gutiérrez-Rodríguez, Marta
- Valenzuela, Carmen
The transient outward potassium current (Itof) is generated by the activation of KV4 chan-
nels assembled with KChIP2 and other accessory subunits (DPP6 and KCNE2). To test the hypothesis
that these subunits modify the channel pharmacology, we analyzed the electrophysiological effects
of (3-(2-(3-phenoxyphenyl)acetamido)-2-naphthoic acid) (IQM-266), a new KChIP2 ligand, on the
currents generated by KV4.3/KChIP2, KV4.3/KChIP2/DPP6 and KV4.3/KChIP2/KCNE2 channels.
CHO cells were transiently transfected with cDNAs codifying for different proteins (KV4.3/KChIP2,
KV4.3/KChIP2/DPP6 or KV4.3/KChIP2/KCNE2), and the potassium currents were recorded using
the whole-cell patch-clamp technique. IQM-266 decreased the maximum peak of KV4.3/KChIP2,
KV4.3/KChIP2/DPP6 and KV4.3/KChIP2/KCNE2 currents, slowing their time course of inactivation
in a concentration-, voltage-, time- and use-dependent manner. IQM-266 produced an increase in
the charge in KV4.3/KChIP2 channels that was intensified when DPP6 was present and abolished
in the presence of KCNE2. IQM-266 induced an activation unblocking effect during the applica-
tion of trains of pulses to cells expressing KV4.3/KChIP2 and KV4.3/KChIP2/KCNE2, but not in
KV4.3/KChIP2/DPP6 channels. Overall, all these results are consistent with a preferential IQM-266
binding to an active closed state of Kv4.3/KChIP2 and Kv4.3/KChIP2/KCNE2 channels, whereas in
the presence of DPP6, IQM-266 binds preferentially to an inactivated state. In conclusion, DPP6 and
KCNE2 modify the pharmacological response of KV4.3/KChIP2 channels to IQM-266., This publication is the results of the: Grants SAF2016-75021-R (to C.V.), RTI2018-097189-B-
C22 (to M.M.-M.) and BIO2017-89523-R (to A.A.) funded by MCIN/AEI/10.13039/501100011033 and
by “ERDF A way of making Europe”; Grants PID2019-104366RB-C21 (to C.V.), PID2019-104366RB-
C22 (to M.G.-R.), PID2020-114256RB-I00 (to A.O. and J.A.G.-V.), PID2020-119805RB-I00 (to A.A.)
funded by MCIN/AEI/10.13039/501100011033; Grant A-FQM-386-UGR20 funded by FEDER/Junta
de Andalucía-Consejería de Transformación Económica, Industria, Conocimiento (to J.A.G.-V.); Grant
CB/11/00222 funded by Instituto de Salud Carlos III CIBERCV (to C.V.); Grants PIE202180E073 (to
M.M.-M. and M.G.-R.), PIE201820E104 and 2019AEP148 (to C.V.) funded by Consejo Superior de
Investigaciones Científicas. Grants BES-2017-080184 (to A.d.B.-B.), BES-2010-036573 (to P.C.), PRE2018-
083280 (to M.D.-M.) and RYC2018-023837-I (to A.P.-L.) funded by MCIN/AEI/10.13039/501100011033
and by “ESF Investing in your future”; Grant FPU17/02731 (to P.G.S.) funded by Ministerio de Ciencia
e Innovación., Peer reviewed